Discovery and exploration of novel somatostatin receptor subtype 5 (SSTR5) antagonists for the treatment of cholesterol gallstones

Authors:

Abstract
No abstract available
Funding Information
  • National Natural Science Foundation of China (82121005, 82273764)
  • State Key Laboratory of Drug Research, Chinese Academy of Sciences
  • Shanghai Institute of Materia Medica, Chinese Academy of Sciences

This publication has 28 references indexed in Scilit: